ATE388946T1 - Cyanamide als reversible hemmer von cystein proteasen - Google Patents
Cyanamide als reversible hemmer von cystein proteasenInfo
- Publication number
- ATE388946T1 ATE388946T1 AT03723865T AT03723865T ATE388946T1 AT E388946 T1 ATE388946 T1 AT E388946T1 AT 03723865 T AT03723865 T AT 03723865T AT 03723865 T AT03723865 T AT 03723865T AT E388946 T1 ATE388946 T1 AT E388946T1
- Authority
- AT
- Austria
- Prior art keywords
- cyanamide
- reversible inhibitor
- cystein proteases
- cysteine proteases
- proteases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37036802P | 2002-04-05 | 2002-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE388946T1 true ATE388946T1 (de) | 2008-03-15 |
Family
ID=29250518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03723865T ATE388946T1 (de) | 2002-04-05 | 2003-04-01 | Cyanamide als reversible hemmer von cystein proteasen |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1495009B1 (de) |
JP (1) | JP2005522489A (de) |
AT (1) | ATE388946T1 (de) |
AU (1) | AU2003230772A1 (de) |
CA (1) | CA2477692A1 (de) |
DE (1) | DE60319686T2 (de) |
ES (1) | ES2301793T3 (de) |
WO (1) | WO2003086325A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090005323A1 (en) * | 2005-01-19 | 2009-01-01 | Michael David Percival | Cathepsin K Inhibitors and Obesity |
US8497271B2 (en) | 2009-10-07 | 2013-07-30 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8304577B2 (en) | 2009-10-09 | 2012-11-06 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
US8703953B2 (en) | 2012-03-09 | 2014-04-22 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
US8901305B2 (en) | 2012-07-31 | 2014-12-02 | Bristol-Myers Squibb Company | Aryl lactam kinase inhibitors |
WO2014130258A1 (en) | 2013-02-22 | 2014-08-28 | Bristol-Myers Squibb Company | 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1) |
EP3019475A1 (de) | 2013-07-08 | 2016-05-18 | Bristol-Myers Squibb Company | Arylamidkinaseinhibitoren |
ES2740224T3 (es) | 2015-04-10 | 2020-02-05 | Bristol Myers Squibb Co | 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155010A1 (de) * | 1999-02-20 | 2001-11-21 | AstraZeneca AB | Acetamido-acetonitril-derivate als cathepsin l- oder cathepsin s-inhibitoren |
AU2001256981A1 (en) * | 2000-04-06 | 2001-10-23 | Axys Pharmaceuticals, Inc. | Cathepsin cysteine protease inhibitors |
-
2003
- 2003-04-01 AU AU2003230772A patent/AU2003230772A1/en not_active Abandoned
- 2003-04-01 DE DE60319686T patent/DE60319686T2/de not_active Expired - Fee Related
- 2003-04-01 EP EP03723865A patent/EP1495009B1/de not_active Expired - Lifetime
- 2003-04-01 WO PCT/US2003/009852 patent/WO2003086325A2/en active Search and Examination
- 2003-04-01 CA CA002477692A patent/CA2477692A1/en not_active Abandoned
- 2003-04-01 AT AT03723865T patent/ATE388946T1/de not_active IP Right Cessation
- 2003-04-01 ES ES03723865T patent/ES2301793T3/es not_active Expired - Lifetime
- 2003-04-01 JP JP2003583350A patent/JP2005522489A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE60319686D1 (de) | 2008-04-24 |
DE60319686T2 (de) | 2009-04-16 |
AU2003230772A1 (en) | 2003-10-27 |
EP1495009A2 (de) | 2005-01-12 |
CA2477692A1 (en) | 2003-10-23 |
AU2003230772A8 (en) | 2003-10-27 |
WO2003086325A3 (en) | 2004-07-01 |
ES2301793T3 (es) | 2008-07-01 |
EP1495009B1 (de) | 2008-03-12 |
JP2005522489A (ja) | 2005-07-28 |
WO2003086325A2 (en) | 2003-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE423108T1 (de) | Nitrile verwendbar als reversible cystein- protease inhibitoren | |
MY132419A (en) | Inhibitors of factor xa and other serine proteases involved in the coagulation cascade | |
TW200635585A (en) | Monocyclic substituted methanones | |
MXPA04001016A (es) | Derivados de sulfonamida como inhibidores de la gamma secretasa. | |
YU17003A (sh) | Spiroheterociklični nitrili upotrebljivi kao reverzibilni inhibitori cisteinskih proteaza | |
WO1999024460A3 (en) | Dipeptide nitriles | |
MY138252A (en) | Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease | |
EP1372655A4 (de) | Cathepsincystein-proteasehemmer | |
ATE516062T1 (de) | Quaternäre ammoniumverbindungen enthaltende wasserfreie zusammensetzungen | |
EA200400815A1 (ru) | Контролируемый синтез зипразидона и его композиции | |
WO2003075836A3 (en) | Cathepsin cysteine protease inhibitors | |
NO20030895L (no) | Ny anvendelse av dipeptidyl peptidase IV inhibitorer | |
SE0201976D0 (sv) | Novel compounds | |
ATE388946T1 (de) | Cyanamide als reversible hemmer von cystein proteasen | |
SG146658A1 (en) | Haloalkyl containing compounds as cysteine protease inhibitors | |
BR0300709A (pt) | Sal de perindopril e as composições farmacêuticas contendo o mesmo | |
ATE368645T1 (de) | Aminosäurederivate als hiv-protease-inhibitoren | |
EA200001152A1 (ru) | СУКЦИНАМИДНЫЕ ИНГИБИТОРЫ ИНТЕРЛЕЙКИН - 1b - КОНВЕРТИРУЮЩЕГО ФЕРМЕНТА | |
ATE365702T1 (de) | Eisenoxide mit höherem veredelungsgrad | |
BG104617A (en) | Novel naphthyl-substituted and anilide-substituted sulfonamides | |
MXPA04005988A (es) | 3,4-dihidro-1h-isoquinolin-2-il-derivados. | |
ATE423102T1 (de) | 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer | |
BRPI0410157A (pt) | bioisostéreos de actinonina | |
ATE472326T1 (de) | Neue zyklische harnstoffe als inhibitoren von metalloproteasen | |
ATE427934T1 (de) | Nicht-peptidische brs-3-agonisten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1495009 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |